Inhaled insulin: Evidence based or industry driven medicine?

BMJ 2006; 332 doi: 10.1136/bmj.332.7552.1273-d (Published 25 May 2006)
Cite this as: BMJ 2006;332:1273.5

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. H Alberti, academic general practitioner (hugh.alberti@newcastle.ac.uk)
  1. Tunis, Tunisia

    EDITOR—Morton-Eggleston and Barrett give a useful, timely description of inhaled insulin to coincide with the recent recommendations from the National Institute for Health and Clinical Excellence (NICE).1 2 But why issue an editorial by authors from the United States, a …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL